/PRNewswire/ - Golden Arrow Resources Corporation (TSXV: GRG) (FSE: G6A) (OTCQB: GARWF), ("Golden Arrow" or the "Company") is pleased to announce it has.
NA Proactive news snapshot: Zynerba Pharmaceuticals, Nerds On Site, Marvel Discovery, Water Tower Research UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psychiatry (SOBP) 2021 Virtual Meeting. The first poster is titled, “Cannabidiol in Fragile X Syndrome (FXS): Proposed Mechanism of Action (MOA) Translates Into Meaningful Clinical Benefits [CONNECT-FX (ZYN2-CL-016)]. The second poster is titled, “A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome [CONNECT-FX (ZYN2-CL-016)].”
Traders send the S&P 500 to a record on busiest day of earnings season
11 of the S&P 500 components are scheduled to issue quarterly reports
4:10pm: Afternoon sees the industrials pick up steam
The Dow came roaring back from a midday dip into the red, closing 241 points higher, 0.7%, at 34,060. The Nasdaq gained 32 points, 0.2%, to 14,083, while the S&P 500 picked up 28 points, 0.7%, to hit nearly 4,212, a record.
Thursday is the biggest day of this earnings season, with 11 of the S&P 500 components scheduled to issue quarterly reports.
McDonald s Corporation (NYSE:MCD) shares gained 1.3% to $235.42 after the company reported before the bell that sales topped pre-coronavirus levels, according to CNBC and others.
NA Proactive news snapshot: Zynerba Pharmaceuticals, Nerds On Site, Marvel Discovery, Water Tower Research UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psychiatry (SOBP) 2021 Virtual Meeting. The first poster is titled, “Cannabidiol in Fragile X Syndrome (FXS): Proposed Mechanism of Action (MOA) Translates Into Meaningful Clinical Benefits [CONNECT-FX (ZYN2-CL-016)]. The second poster is titled, “A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome [CONNECT-FX (ZYN2-CL-016)].”
Golden Arrow Provides Exploration Update and Reports Trench Results from Flecha de Oro Project, Argentina
News provided by
Share this article
Golden Arrow Resources Corporation (TSXV: GRG) (FSE: G6A) (OTCQB: GARWF),
( Golden Arrow or the Company ) is pleased to provide an update on exploration activities at its three most active projects, including the first results from the on-going trenching program at the Esperanza property of the Flecha de Oro gold project, Argentina.
Phase I of the trenching program at Esperanza is focused on a nine square kilometre area where numerous gold-bearing quartz-veins have been identified at surface. Of particular note are results from a single vein, mapped over 540 metres of strike extent, that returned significant gold intervals in two separate trenches located approximately 160 metres apart, including: